This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Clinical Experience With Insulin Resistance, Diabetic Ketoacidosis, and Type 2 Diabetes Mellitus in Patients Treated With Atypical Antipsychotic Agents

Article Abstract

Numerous reports have associated atypical antipsychotic agents with hyperglycemia, diabetesmellitus, and diabetic ketoacidosis. Although the mechanisms are poorly understood, clinical experiencesuggests that these adverse effects are major areas of concern and require attention by the psychiatricteam and primary care clinicians. This article discusses my clinical experience with glucosemetabolism impairment related to treatment with antipsychotic medications.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 62

Quick Links: Metabolic Disorder , Side Effects-Medication